The Patent Finder
AB

Ardea Biosciences, Inc.

First filing 2005
OverviewNotableFeesChangesFamiliesPatent listSources & methods

16 patents currently held

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in Nov 2028. from the record

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
8
Ending by 2030
Nov 2028
Next term end
5
Patent families

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
notable patents all others Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Jun 22, 2027
    The maintenance fee for Treatment of Gout and Hyperuricemia (US 9,216,179) comes due Jun 22, 2027. Unpaid by Dec 22, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

What they patent

Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.
PatentTitleStatusExpiresConfidence
US 8,283,369Novel Compounds and Compositions and Methods of Use
In force
 · Medium confidence
In forceMedium confidence
US 8,633,232Compounds, Compositions and Methods of Using Same for Modulating Uric Acid Levels
In force
 · Medium confidence
In forceMedium confidence
US 10,183,012Novel Compounds and Compositions and Methods of Use
In force
 · Medium confidence
In forceMedium confidence
US 8,546,437Novel Compounds and Compositions and Methods of Use
In force
 · High confidence
In forceHigh confidence
US 8,084,483Novel Compounds and Compositions and Methods of Use
In force
 · High confidence
In forceHigh confidence
US 8,242,154Compounds, Compositions and Methods of Using Same for Modulating Uric Acid Levels
In force
 · Medium confidence
In forceMedium confidence
US 8,173,690Compounds, Compositions and Methods of Using Same for Modulating Uric Acid Levels
In force
 · High confidence
In forceHigh confidence
US 8,357,713Novel Compounds and Compositions and Methods of Use
In force
 · High confidence
In forceHigh confidence
US 8,541,589Thioacetate Compounds, Compositions and Methods of Use
In force
 · High confidence
In forceHigh confidence
US 8,629,278Thioacetate Compounds, Compositions and Methods of Use
In force
 · High confidence
In forceHigh confidence
10 of 16 patents shown.
Pro members see all 16.
Pro members: see all 16 patents
Also on record, not counted in the 16: 47 patents ended · 45 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited